Key Findings
The study demonstrates that cancer cachexia induces significant wasting and dysfunction in human iPSC-derived cardiac muscle. Using a specialized modeling platform, researchers observed that cachectic hiPSC-CMs exhibit cellular atrophy, reduced contraction amplitude, and prolonged relaxation time. Additionally, these cells show an elevated oxygen consumption rate, indicating a state of metabolic dysregulation.
Technical Details
To simulate the effects of cancer cachexia, the research team utilized a human induced pluripotent stem cell–derived cardiac myocyte (hiPSC-CM) platform. The model was implemented using two primary methods:
- Conditioned media from tumor cells.
- Transwell coculture with C26 or HCT116 tumor cells.
Mechanistically, the wasting process is linked to the suppression of the AKT/mTORC1/S6 signaling axis. Specifically, the researchers noted a reduction in total and p-AKT levels, as well as a decrease in the p-S6/S6 ratio.
Background & Context
Cancer cachexia is a debilitating syndrome characterized by involuntary body mass loss and profound skeletal muscle wasting, which is associated with high mortality rates. While skeletal muscle is a primary focus of cachexia research, cardiac muscle wasting is also prominent in both cancer patients and cancer survivors.
Significance & Outlook
By elucidating the aberrant signaling pathways—specifically the AKT/mTORC1/S6 axis—this research provides a mechanistic understanding of how tumor cells trigger cardiac wasting. The development of the hiPSC-CM platform allows for the study of human-specific cardiac responses to cancer-induced wasting, offering a foundation for understanding the metabolic and contractile failures associated with the syndrome.
Source: https://doi.org/10.1172/jci.insight.203276
Get our weekly technology intelligence — free
Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.
Subscribe Free — Weekly Tech Intelligence
By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.
- Your email and selected fields are used only to deliver the newsletter.
- We never share your information with third parties.
- You can unsubscribe anytime via the link in each email.
See our Privacy Policy for details.
Takes about a minute · Unsubscribe anytime



